about
Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association studyEliminate now: seven critical actions required to accelerate elimination of Plasmodium falciparum malaria in the Greater Mekong SubregionRecent advances in malaria genomics and epigenomicsArtemisinin Action and Resistance in Plasmodium falciparumEvidence of a Mild Mutator Phenotype in Cambodian Plasmodium falciparum Malaria ParasitesEvolution of Fitness Cost-Neutral Mutant PfCRT Conferring P. falciparum 4-Aminoquinoline Drug Resistance Is Accompanied by Altered Parasite Metabolism and Digestive Vacuole PhysiologySouth-East Asian strains of Plasmodium falciparum display higher ratio of non-synonymous to synonymous polymorphisms compared to African strainsMicro-epidemiological structuring of Plasmodium falciparum parasite populations in regions with varying transmission intensities in AfricaLongitudinal genomic surveillance of Plasmodium falciparum malaria parasites reveals complex genomic architecture of emerging artemisinin resistanceDrug resistance in eukaryotic microorganisms.Plasmodium falciparum K13 Mutations Differentially Impact Ozonide Susceptibility and Parasite Fitness In Vitro.Extreme mutation bias and high AT content in Plasmodium falciparum.A Variant PfCRT Isoform Can Contribute to Plasmodium falciparum Resistance to the First-Line Partner Drug PiperaquineThe clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.High throughput resistance profiling of Plasmodium falciparum infections based on custom dual indexing and Illumina next generation sequencing-technology.Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes.Independent Origin and Global Distribution of Distinct Plasmodium vivax Duffy Binding Protein Gene DuplicationsTHE REAL McCOIL: A method for the concurrent estimation of the complexity of infection and SNP allele frequency for malaria parasites.Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies.Limited Polymorphism of the Kelch Propeller Domain in Plasmodium malariae and P. ovale Isolates from ThailandContinued Sensitivity of Plasmodium falciparum to Artemisinin in Guyana, With Absence of Kelch Propeller Domain Mutant Alleles.Genome-wide diversity and gene expression profiling of Babesia microti isolates identify polymorphic genes that mediate host-pathogen interactions.Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration.Population Parameters Underlying an Ongoing Soft Sweep in Southeast Asian Malaria Parasites.Overlap Extension Barcoding for the Next Generation Sequencing and Genotyping of Plasmodium falciparum in Individual Patients in Western Kenya.Molecular surveillance of artemisinin resistance falciparum malaria among migrant goldmine workers in MyanmarClinical and molecular surveillance of artemisinin resistant falciparum malaria in Myanmar (2009-2013).Genome-wide diversity and differentiation in New World populations of the human malaria parasite Plasmodium vivax.Malaria Genomics in the Era of Eradication.Molecular Profile of Malaria Drug Resistance Markers of Plasmodium falciparum in Suriname.Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.Genomic Characterization of Recrudescent Plasmodium malariae after Treatment with Artemether/Lumefantrine.Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia.Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic.Molecular Epidemiology of Plasmodium falciparum kelch13 Mutations in Senegal Determined by Using Targeted Amplicon Deep Sequencing.Longitudinal Pooled Deep Sequencing of the Plasmodium vivax K12 Kelch Gene in Cambodia Reveals a Lack of Selection by Artemisinin.Sustained Ex Vivo Susceptibility of Plasmodium falciparum to Artemisinin Derivatives but Increasing Tolerance to Artemisinin Combination Therapy Partner Quinolines in The Gambia.K13-propeller Alleles, Mdr1 Polymorphism, and Drug Effectiveness at Day 3 after Artemether-lumefantrine Treatment for Plasmodium falciparum Malaria in Colombia, 2014-2015.The threat of artemisinin resistant malaria in Southeast Asia.Plasmodium falciparum parasites with histidine-rich protein 2 (pfhrp2) and pfhrp3 gene deletions in two endemic regions of Kenya.
P2860
Q27861941-22B5661F-89FD-498F-8ED8-6E9D20660478Q27928006-F25DD8A9-D3AC-4752-AC22-FC1888596BAEQ28069435-FF602896-1CEF-434E-AD92-EB34CF6784C4Q28276294-494D3FDD-C859-4B86-AA97-5336778BB894Q28551519-E95594BA-EC01-4CFF-B160-43D752832860Q28553454-7D6C7882-47A3-4D38-922D-3B818CEF0BDFQ28596723-2DB5FBC1-A156-48BA-AE7C-8835F14198F3Q29464553-352AEC76-7A7E-47C1-9528-7877FC0849E7Q30044965-B954DEBE-33C0-445E-A1BC-B508E3E8240CQ30248243-658428F7-C3BA-45BD-BC9A-732DBFBB4DD6Q33555297-49F5D446-9480-426F-A00E-D645129F49CCQ33558392-E288AE1F-C83F-4CC7-93B2-DBD41A7C774BQ33654512-1877B8F4-8DF5-480F-8F07-76DA5E0065B3Q33655603-00DE1A1F-F768-4E64-9951-0551EDB5CECBQ33729200-AB6AB2DA-CF0E-4239-A951-BF0AA77F8AB6Q33902615-0F519211-0FD6-45F4-9883-1E1BE3CC57B7Q36178527-F8C79AA2-5ED8-46EF-9CEA-B09173AE6571Q36260900-4D6CD695-41CD-4F66-A33D-BD9C355F9036Q36919648-13BBD455-15EC-4873-9D35-3BFF5132BF29Q37023169-FCE7F3BA-07C8-451D-8317-AD2DCC4CBEE0Q37305591-1ABDD7EB-049B-4C79-AB79-72E10B8EE759Q37371541-AB1918DE-CDBA-4872-BECE-831E8AC4B2AAQ37402952-0F688816-D289-475D-A26C-46E247091E1FQ37564232-D5844603-4509-4143-91C0-B43221D38944Q37602150-2C7DF8D1-D37D-4AF6-935C-15C7022C2A0FQ37676836-358FA215-F9D9-4867-B274-7E5607BDFB5CQ38372219-FC447BBD-2211-437D-891D-B5F7DEBB2DF6Q38651624-721C1991-506C-4B5D-B1C1-E54B51238741Q38733344-7756F7AA-1F11-42EC-A88F-470C7B92DEE7Q38822049-B88D9466-CCE3-441C-B06D-3370307A008CQ38867438-19F23384-9820-4268-9836-2F005CD22E2AQ39254449-2C58D576-8E08-4E14-B11D-6D70C6D60B8AQ40064790-9E85BD60-427D-4E13-A6BC-BEB1FD8ED974Q40106428-A1A345AE-A270-47A2-A85B-0ED69A23B9B4Q40378874-BF777470-BB54-4D47-9665-A2261F2241E0Q40472898-A03109A3-6086-4DC7-AC00-F8CBA244331BQ41911850-A9036078-8821-4549-8931-98628D150E31Q41911890-68676431-9714-4447-B424-80DD04794F68Q42343414-143C72EE-84F1-4895-9E6E-88772C6D1B23Q44157364-C64BBE93-D1CD-4EE9-BDC4-390A3ABA91AB
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Genomic epidemiology of artemisinin resistant malaria
@ast
Genomic epidemiology of artemisinin resistant malaria
@en
type
label
Genomic epidemiology of artemisinin resistant malaria
@ast
Genomic epidemiology of artemisinin resistant malaria
@en
prefLabel
Genomic epidemiology of artemisinin resistant malaria
@ast
Genomic epidemiology of artemisinin resistant malaria
@en
P2860
P921
P356
P1433
P1476
Genomic epidemiology of artemisinin resistant malaria
@en
P2093
MalariaGEN Plasmodium falciparum Community Project
P2860
P356
10.7554/ELIFE.08714
P407
P577
2016-03-04T00:00:00Z